Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D E Moller

Showing results (71-80 of 92) with videos related to

Pageof 10
Sort By:
Diabetes|January 1, 1993
Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cellsN Kaiser, S Sasson, E P Feener, et al.
Journal of Clinical Pharmacology|April 16, 2005
Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteersJ A Wagner, P J Larson, S Weiss, et al.
Diabetologia|March 30, 1999
Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animalsM L Goalstone, K Wall, J W Leitner, et al.
The Journal of Biological Chemistry|March 13, 1999
L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand bindingA Elbrecht, Y Chen, A Adams, et al.
The Journal of Biological Chemistry|February 21, 1997
Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoterA N Hollenberg, V S Susulic, J P Madura, et al.
The Journal of Biological Chemistry|July 25, 1992
Relation between the insulin receptor number in cells, autophosphorylation and insulin-stimulated Ras.GTP formationA P Osterop, R H Medema, J L Bos, et al.
The Journal of Clinical Investigation|December 1, 1990
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemiaA C Moses, H N Rosen, D E Moller, et al.
Molecular Endocrinology (Baltimore, Md.)|October 17, 1998
Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transferG Zhou, R Cummings, Y Li, et al.
Endocrinology|December 1, 1998
Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) actionJ R Zierath, J W Ryder, T Doebber, et al.
Journal of Medicinal Chemistry|September 23, 2000
Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptorK Liu, L Xu, D Szalkowski, et al.
Pageof 10

Showing results (71-80 of 92) with videos related to

Sort By:
Pageof 10
Diabetes|January 1, 1993
Differential regulation of glucose transport and transporters by glucose in vascular endothelial and smooth muscle cellsN Kaiser, S Sasson, E P Feener, et al.
Journal of Clinical Pharmacology|April 16, 2005
Individual and combined effects of peroxisome proliferator-activated receptor and {gamma} agonists, fenofibrate and rosiglitazone, on biomarkers of lipid and glucose metabolism in healthy nondiabetic volunteersJ A Wagner, P J Larson, S Weiss, et al.
Diabetologia|March 30, 1999
Increased amounts of farnesylated p21Ras in tissues of hyperinsulinaemic animalsM L Goalstone, K Wall, J W Leitner, et al.
The Journal of Biological Chemistry|March 13, 1999
L-764406 is a partial agonist of human peroxisome proliferator-activated receptor gamma. The role of Cys313 in ligand bindingA Elbrecht, Y Chen, A Adams, et al.
The Journal of Biological Chemistry|February 21, 1997
Functional antagonism between CCAAT/Enhancer binding protein-alpha and peroxisome proliferator-activated receptor-gamma on the leptin promoterA N Hollenberg, V S Susulic, J P Madura, et al.
The Journal of Biological Chemistry|July 25, 1992
Relation between the insulin receptor number in cells, autophosphorylation and insulin-stimulated Ras.GTP formationA P Osterop, R H Medema, J L Bos, et al.
The Journal of Clinical Investigation|December 1, 1990
A point mutation in transthyretin increases affinity for thyroxine and produces euthyroid hyperthyroxinemiaA C Moses, H N Rosen, D E Moller, et al.
Molecular Endocrinology (Baltimore, Md.)|October 17, 1998
Nuclear receptors have distinct affinities for coactivators: characterization by fluorescence resonance energy transferG Zhou, R Cummings, Y Li, et al.
Endocrinology|December 1, 1998
Role of skeletal muscle in thiazolidinedione insulin sensitizer (PPARgamma agonist) actionJ R Zierath, J W Ryder, T Doebber, et al.
Journal of Medicinal Chemistry|September 23, 2000
Discovery of a potent, highly selective, and orally efficacious small-molecule activator of the insulin receptorK Liu, L Xu, D Szalkowski, et al.
Pageof 10